USD 68.93
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| OPY | 1.4 | 10.6 | 12.8 | 36.6 | 30.8 | 78.0 | 53.8 | 152.2 | 227.8 | 980.4 |
| S&P 500 | 1.0 | 3.7 | 2.1 | 2.3 | 8.2 | 25.4 | 31.0 | 80.6 | 196.5 | 33856.2 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | OPY |
| name | Oppenheimer Holdings Inc. |
| price | 68.93 |
| changes percentage | 1.3826 |
| change | 0.94 |
| day low | 67.73 |
| day high | 69.1899 |
| year high | 70.25 |
| year low | 36.93 |
| market cap | 705271081 |
| price avg 50 | 62.6728 |
| price avg 200 | 51.3555 |
| exchange | NYSE |
| volume | 17900 |
| avg volume | 31240 |
| open | 68.27 |
| previous close | 67.99 |
| eps | 6.42 |
| pe | 10.74 |
| earnings announcement | 2025-01-24T13:30:00.000+0000 |
| shares outstanding | 10231700 |
| timestamp | 2025-01-17 21:00:02 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0000791963 | |||
| revenue | 1248825000 | 1110941000 | 12.41 |
| gross profit | 441501000 | 344548000 | 28.14 |
| gross profit ratio | 0.35 | 0.31 | 13.99 |
| research and development expenses | 0 | 0.04 | -100.00 |
| operating expenses | 1133391000 | 145371000 | 679.65 |
| interest income | 0 | 0 | NaN |
| interest expense | 68599000 | 23846000 | 187.68 |
| ebitda | 152574000 | 69400000 | 119.85 |
| ebitdaratio | 0.12 | 0.06 | 95.57 |
| operating income | 0 | 34991000 | -100.00 |
| operating income ratio | 0 | 0.03 | -100.00 |
| net income | 30179000 | 32351000 | -6.71 |
| net income ratio | 0.02 | 0.03 | -17.01 |
| eps | 2.81 | 2.77 | 1.44 |
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0000791963 | |||
| revenue | 373352000 | 330589000 | 12.94 |
| gross profit | 128292000 | 314535001 | -59.21 |
| gross profit ratio | 0.34 | 0.95 | -63.88 |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 128292000 | 40198000 | 219.15 |
| interest income | 0 | 0 | NaN |
| interest expense | 24103000 | 21980000 | 9.66 |
| ebitda | 68879000 | 47119000 | 46.18 |
| ebitdaratio | 0.18 | 0.14 | 29.44 |
| operating income | 87450000 | 37845000 | 131.07 |
| operating income ratio | 0.23 | 0.11 | 104.61 |
| net income | 24508000 | 10266000 | 138.73 |
| net income ratio | 0.07 | 0.03 | 111.39 |
| eps | 2.37 | 0.99 | 139.39 |
Revenue Growth: revenue increased to 373 million in 2024Q3 from 331 million in 2024Q2 representing a change of 12.94%. This indicates a sales growth, which is a positive sign for the company.
Operating Expenses: Operating Expenses decreased to 128 million in 2024Q3 from 40 million in 2024Q2 representing a change of 219.15%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 69 million in 2024Q3 from 47 million in 2024Q2 representing a change of 46.18%. The increase in EBITDA indicates improved operational efficiency and profitability.
Operating Income: Operating income increased to 87 million in 2024Q3 from 38 million in 2024Q2 representing a change of 131.07%. The increase in operating income indicates better operational performance and increased profitability.
Net Income: Net income increased to 25 million in 2024Q3 from 10 million in 2024Q2 representing a change of 138.73%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to 2.37 in 2024Q3 from 2.37 in 2024Q2 representing a change of 139.39%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.
Gross Profit: Gross Profit decreased to 128 million in 2024Q3 from 315 million in 2024Q2 representing a change of -59.21%. This indicates a sales profitability decline, which is a negative sign for the company.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0000791963 | |||
| total assets | 2874816000 | 2714392000 | 5.91 |
| total liabilities | 2085577000 | 1893971000 | 10.12 |
| total equity | 789239000 | 820421000 | -3.80 |
| cash and cash equivalents | 28835000 | 112433000 | -74.35 |
| short term investments | 0 | 0 | NaN |
| long term investments | 111773000 | 322870000 | -65.38 |
| total current assets | 2211349000 | 1857718000 | 19.04 |
| total non current assets | 663467000 | 856674000 | -22.55 |
| total current liabilities | 529000000 | 791970000 | -33.20 |
| total non current liabilities | 1829333000 | 1102001000 | 66.00 |
| common stock | 10000 | 11000 | -9.09 |
| retained earnings | 756468000 | 764178000 | -1.01 |
| total debt | 593566000 | 794237000 | -25.27 |
Total Assets: Total Assets increased to 2,875 million in 2023 from 2,714 million in 2022 representing a change of 5.91%. Suggesting a growth in asset holdings.
Total Current Assets: Total Current Assets increased to 2,211 million in 2023 from 1,858 million in 2022 representing a change of 19.04%. This indicates a better liquidity position.
Total Current Liabilities: Total Current Liabilities decreased to 529 million in 2023 from 792 million in 2022 representing a change of -33.2%. This indicates a lower short-term debt burden.
Total Debt: Total Debt decreased to 594 million in 2023 from 794 million in 2022 representing a change of -25.27%. This indicates a reduction in overall debt burden.
Total Liabilities: Total Liabilities increased to 2,086 million in 2023 from 1,894 million in 2022 representing a change of 10.12%. This indicates an increase in overall liabilities.
Total Equity: Total Equity decreased to 789 million in 2023 from 820 million in 2022 representing a change of -3.8%. This indicates a decrease in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 29 million in 2023 from 112 million in 2022 representing a change of -74.35%. This indicates a decrease in available liquid assets.
Common Stock: Common Stock decreased to 0 in 2023 from 0 in 2022 representing a change of -9.09%. This indicates a decrease in ownership interest.
Retained Earnings: Retained Earnings decreased to 756 million in 2023 from 764 million in 2022 representing a change of -1.01%. This indicates an accumulated losses.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0000791963 | |||
| total assets | 3367285000 | 3306625000 | 1.83 |
| total liabilities | 2529447000 | 2494565000 | 1.40 |
| total equity | 837838000 | 812060000 | 3.17 |
| cash and cash equivalents | 32242000 | 33214000 | -2.93 |
| short term investments | 0 | -508849000 | 100.00 |
| long term investments | 275168000 | 179994000 | 52.88 |
| total current assets | 2556562000 | 2537037000 | 0.77 |
| total non current assets | 810723000 | 725501000 | 11.75 |
| total current liabilities | 490450000 | 447842000 | 9.51 |
| total non current liabilities | 2038997000 | 2002636000 | 1.82 |
| common stock | 10000 | 10000 | 0.00 |
| retained earnings | 811092000 | 788739000 | 2.83 |
| total debt | 781807000 | 1348718000 | -42.03 |
Total Assets: Total Assets increased to 3,367 million in 2024Q3 from 3,307 million in 2024Q2 representing a change of 1.83%. Suggesting a growth in asset holdings.
Total Equity: Total Equity increased to 838 million in 2024Q3 from 812 million in 2024Q2 representing a change of 3.17%. This indicates an increase in shareholders' equity.
Short Term Investments: Short Term Investments increased to 0 million in 2024Q3 from -509 million in 2024Q2 representing a change of 100.0%. This indicates an increase in short-term investment holdings.
Total Current Assets: Total Current Assets increased to 2,557 million in 2024Q3 from 2,537 million in 2024Q2 representing a change of 0.77%. This indicates a better liquidity position.
Retained Earnings: Retained Earnings increased to 811 million in 2024Q3 from 789 million in 2024Q2 representing a change of 2.83%. This indicates an accumulated profits.
Total Debt: Total Debt decreased to 782 million in 2024Q3 from 1,349 million in 2024Q2 representing a change of -42.03%. This indicates a reduction in overall debt burden.
Total Liabilities: Total Liabilities increased to 2,529 million in 2024Q3 from 2,495 million in 2024Q2 representing a change of 1.4%. This indicates an increase in overall liabilities.
Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 32 million in 2024Q3 from 33 million in 2024Q2 representing a change of -2.93%. This indicates a decrease in available liquid assets.
Total Current Liabilities: Total Current Liabilities increased to 490 million in 2024Q3 from 448 million in 2024Q2 representing a change of 9.51%. This indicates a higher short-term debt burden.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0000791963 | |||
| net change in cash | -109132000 | -203557000 | 46.39 |
| operating cash flow | -18810000 | 64492000 | -129.17 |
| free cash flow | -35866000 | 48181000 | -174.44 |
| capital expenditure | -17056000 | -16311000 | -4.57 |
| depreciation and amortization | 37205000 | 34409000 | 8.13 |
| deferred income tax | 6457000 | -14616000 | 144.18 |
| stock based compensation | 17008195 | 15915702 | 6.86 |
| accounts payables | -323325000 | -139000 | -232507.91 |
| inventory | 0 | 0 | NaN |
| acquisitions net | -2929000 | 76998000 | -103.80 |
| investments in property plant and equipment | -17056000 | -16311000 | -4.57 |
| net cash used for investing activites | -15561000 | -14137000 | -10.07 |
| debt repayment | -1000000 | -80450000 | 98.76 |
| common stock issued | 75000 | 127000 | -40.94 |
| common stock repurchased | -35124000 | -60636000 | 42.07 |
| dividends paid | -6452000 | -7044000 | 8.40 |
| net cash used provided by financing activities | -74761000 | -253912000 | 70.56 |
| cash at end of period | 28835000 | 137967000 | -79.10 |
| accounts receivables | 35948000 | 21641000 | 66.11 |
| cash at beginning of period | 137967000 | 341524000 | -59.60 |
Net Change in Cash: Net Change in Cash increased to -109 million in 2023 from -204 million in 2022 representing a change of 46.39%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Capital Expenditure: Capital Expenditure decreased to -17 million in 2023 from -16 million in 2022 representing a change of -4.57%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Dividends Paid: Dividends Paid increased to -6 million in 2023 from -7 million in 2022 representing a change of 8.4%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.
Operating Cash Flow: Operating Cash Flow decreased to -19 million in 2023 from 64 million in 2022 representing a change of -129.17%. This indicates that the company generated less cash from its core business operations.
Free Cash Flow: Free Cash Flow decreased to -36 million in 2023 from 48 million in 2022 representing a change of -174.44%. This indicates a decrease in cash generated after accounting for capital expenditures.
Deferred Income Tax: Deferred Income Tax increased to 6 million in 2023 from -15 million in 2022 representing a change of 144.18%. This indicates that the company's tax liability for future periods has increased.
Stock-Based Compensation: Stock-Based Compensation increased to 17 million in 2023 from 16 million in 2022 representing a change of 6.86%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables increased to 323 million in 2023 from 0 million in 2022 representing a change of -232507.91%. This indicates that the company has increased its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables increased to 36 in 2023 from 22 million in 2022 representing a change of 66.11%. This suggests that the company is less capable of collecting payments from its customers.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0000791963 | |||
| operating cash flow | 74361000 | -309062000 | 124.06 |
| free cash flow | 11214000 | -310471000 | 103.61 |
| capital expenditure | -220000 | -1409000 | 84.39 |
| depreciation and amortization | 9406000 | 9274000 | 1.42 |
| deferred income tax | 7415000 | 503000 | 1374.16 |
| stock based compensation | 7332000 | 12699000 | -42.26 |
| accounts receivables | 114003000 | -18416000 | 719.04 |
| accounts payables | 70936000 | -362119000 | 119.59 |
| inventory | 0 | 0 | NaN |
| acquisitions net | 0 | 0 | NaN |
| investments in property plant and equipment | -220000 | -1409000 | 84.39 |
| net cash used for investing activites | -49518000 | 192336000 | -125.75 |
| debt repayment | -12100000 | 124753000 | -109.70 |
| common stock issued | 64000 | 0 | NaN |
| common stock repurchased | -294000 | -925000 | 68.22 |
| dividends paid | -1860000 | -1549000 | -20.08 |
| net cash used provided by financing activities | -25815000 | 122279000 | -121.11 |
| net change in cash | -972000 | 5553000 | -117.50 |
| cash at end of period | 32242000 | 33214000 | -2.93 |
| cash at beginning of period | 33214000 | 27661000 | 20.08 |
Net Change in Cash: Net Change in Cash decreased to -1 million in 2024Q3 from 6 million in 2024Q2 representing a change of -117.5%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.
Capital Expenditure: Capital Expenditure increased to 0 million in 2024Q3 from -1 million in 2024Q2 representing a change of 84.39%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.
Deferred Income Tax: Deferred Income Tax increased to 7 million in 2024Q3 from 1 million in 2024Q2 representing a change of 1374.16%. This indicates that the company's tax liability for future periods has increased.
Accounts Receivables: Accounts Receivables increased to 114 in 2024Q3 from -18 million in 2024Q2 representing a change of 719.04%. This suggests that the company is less capable of collecting payments from its customers.
Dividends Paid: Dividends Paid decreased to -2 million in 2024Q3 from -2 million in 2024Q2 representing a change of -20.08%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.
Operating Cash Flow: Operating Cash Flow increased to 74 million in 2024Q3 from -309 million in 2024Q2 representing a change of 124.06%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to 11 million in 2024Q3 from -310 million in 2024Q2 representing a change of 103.61%. This indicates an increase in cash generated after accounting for capital expenditures.
Stock-Based Compensation: Stock-Based Compensation decreased to 7 million in 2024Q3 from 13 million in 2024Q2 representing a change of -42.26%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables decreased to 71 million in 2024Q3 from 362 million in 2024Q2 representing a change of 119.59%. This indicates that the company has reduced its outstanding obligations to its suppliers.
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2023-12-31 | 2022-12-31 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2023 | 2022 | NaN |
| revenue per share | 116.32 | 95.23 | 22.15 |
| net income per share | 2.81 | 2.77 | 1.37 |
| operating cash flow per share | -1.75 | 5.53 | -131.69 |
| free cash flow per share | -3.34 | 4.13 | -180.89 |
| cash per share | 2.69 | 9.64 | -72.13 |
| book value per share | 73.51 | 70.32 | 4.53 |
| tangible book value per share | 57.07 | 55.75 | 2.37 |
| shareholders equity per share | 73.51 | 68.08 | 7.97 |
| interest debt per share | 61.68 | 70.12 | -12.05 |
| market cap | 443618379.12 | 493829992.02 | -10.17 |
| enterprise value | 1008349379.12 | 1175633992.02 | -14.23 |
| pe ratio | 14.7 | 15.26 | -3.70 |
| price to sales ratio | 0.36 | 0.44 | -20.09 |
| pocfratio | -23.58 | 7.66 | -408.00 |
| pfcf ratio | -12.37 | 10.25 | -220.68 |
| pb ratio | 0.56 | 0.62 | -9.59 |
| ptb ratio | 0.56 | 0.62 | -9.59 |
| ev to sales | 0.81 | 1.06 | -23.70 |
| enterprise value over ebitda | 6.61 | 16.94 | -60.99 |
| ev to operating cash flow | -53.61 | 18.23 | -394.07 |
| ev to free cash flow | -28.11 | 24.4 | -215.22 |
| earnings yield | 0.07 | 0.07 | 3.84 |
| free cash flow yield | -0.08 | 0.1 | -182.87 |
| debt to equity | 0.75 | 1.0 | -24.79 |
| debt to assets | 0.21 | 0.29 | -29.44 |
| net debt to ebitda | 3.7 | 9.82 | -62.32 |
| current ratio | 4.18 | 2.35 | 78.21 |
| interest coverage | 0 | 1.47 | -100.00 |
| income quality | -0.62 | 2.01 | -131.03 |
| dividend yield | 0.01 | 0.01 | 1.96 |
| payout ratio | 0.21 | 0.22 | -1.81 |
| sales general and administrative to revenue | 0.13 | 0.13 | -3.73 |
| research and ddevelopement to revenue | 0 | 0.0 | -100.00 |
| intangibles to total assets | 0.06 | 0.06 | -1.96 |
| capex to operating cash flow | -0.91 | 0.25 | -458.52 |
| capex to revenue | 0.01 | 0.01 | -6.98 |
| capex to depreciation | 0.46 | 0.47 | -3.29 |
| stock based compensation to revenue | 0.01 | 0.01 | -4.93 |
| graham number | 68.18 | 65.17 | 4.62 |
| roic | 0 | 0.01 | -100.00 |
| return on tangible assets | 0.01 | 0.01 | -12.03 |
| graham net net | -92.76 | -58.44 | -58.73 |
| working capital | 1682349000 | 1065748000 | 57.86 |
| tangible asset value | 612737000 | 650432000 | -5.80 |
| net current asset value | 125772000 | -36253000 | 446.93 |
| invested capital | 2043279000 | 1415109000 | 44.39 |
| average receivables | 1440381500 | 1455835500 | -1.06 |
| average payables | 92506000 | 89428500 | 3.44 |
| average inventory | 0 | 990796000 | -100.00 |
| days sales outstanding | 413.4 | 481.77 | -14.19 |
| days payables outstanding | 37.44 | 48.67 | -23.08 |
| days of inventory on hand | 0 | 0 | NaN |
| receivables turnover | 0.88 | 0.76 | 16.54 |
| payables turnover | 9.75 | 7.5 | 30.01 |
| inventory turnover | 0 | 0 | NaN |
| roe | 0.04 | 0.04 | -6.11 |
| capex per share | 1.59 | 1.4 | 13.63 |
ROE: Return on Equity (ROE) decreased to 0.04 on 2023-12-31 from 0.04 on 2022-12-31, representing a change of -6.11%. Suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 14.70 on 2023-12-31 from 15.26 on 2022-12-31, representing a change of -3.70%. Indicating a decrease in the relative valuation of the company's stock.
Current Ratio: Current Ratio increased to 4.18 on 2023-12-31 from 2.35 on 2022-12-31, representing a change of 78.21%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.75 on 2023-12-31 from 1.00 on 2022-12-31, representing a change of -24.79%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
| 2024-09-30 Q3 | 2024-06-30 Q2 | Q/Q change % | |
|---|---|---|---|
| OPY | |||
| calendar year | 2024 | 2024 | NaN |
| revenue per share | 36.13 | 32.01 | 12.88 |
| net income per share | 2.37 | 0.99 | 138.61 |
| operating cash flow per share | 7.2 | -29.93 | 124.05 |
| free cash flow per share | 1.09 | -30.06 | 103.61 |
| cash per share | 3.12 | -46.05 | 106.78 |
| book value per share | 81.08 | 78.63 | 3.12 |
| tangible book value per share | 64.02 | 61.55 | 4.02 |
| shareholders equity per share | 81.08 | 78.63 | 3.12 |
| interest debt per share | 77.99 | 132.72 | -41.23 |
| market cap | 528632545.32 | 507715532.88 | 4.12 |
| enterprise value | 1278197545.32 | 1823219532.88 | -29.89 |
| pe ratio | 5.39 | 12.36 | -56.39 |
| price to sales ratio | 1.42 | 1.54 | -7.81 |
| pocfratio | 7.11 | -1.64 | 532.75 |
| pfcf ratio | 47.14 | -1.64 | 2982.66 |
| pb ratio | 0.63 | 0.63 | 0.92 |
| ptb ratio | 0.63 | 0.63 | 0.92 |
| ev to sales | 3.42 | 5.52 | -37.92 |
| enterprise value over ebitda | 18.56 | 38.69 | -52.04 |
| ev to operating cash flow | 17.19 | -5.9 | 391.38 |
| ev to free cash flow | 113.98 | -5.87 | 2040.97 |
| earnings yield | 0.05 | 0.02 | 129.28 |
| free cash flow yield | 0.02 | -0.61 | 103.47 |
| debt to equity | 0.93 | 1.66 | -43.82 |
| debt to assets | 0.23 | 0.41 | -43.08 |
| net debt to ebitda | 10.88 | 27.92 | -61.02 |
| current ratio | 5.21 | 5.67 | -7.98 |
| interest coverage | 3.63 | 1.72 | 110.72 |
| income quality | 3.03 | -30.11 | 110.08 |
| dividend yield | 0.0 | 0.0 | 15.33 |
| payout ratio | 0.08 | 0.15 | -49.70 |
| sales general and administrative to revenue | 0.11 | 0.12 | -10.04 |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0.05 | 0.05 | -1.84 |
| capex to operating cash flow | 0.0 | -0.0 | 164.90 |
| capex to revenue | 0.0 | 0.0 | -86.17 |
| capex to depreciation | 0.02 | 0.15 | -84.61 |
| stock based compensation to revenue | 0.02 | 0.04 | -48.88 |
| graham number | 65.78 | 41.94 | 56.86 |
| roic | 0.02 | 0.01 | 235.45 |
| return on tangible assets | 0.01 | 0.0 | 134.19 |
| graham net net | -122.46 | -176.62 | 30.67 |
| working capital | 2066112000 | 2089195000 | -1.10 |
| tangible asset value | 661565000 | 635711000 | 4.07 |
| net current asset value | 27115000 | 42472000 | -36.16 |
| invested capital | 2408734000 | 2438148000 | -1.21 |
| average receivables | 1585277000 | 1520441000 | 4.26 |
| average payables | 66995000 | 76019500 | -11.87 |
| average inventory | 0 | 0 | NaN |
| days sales outstanding | 395.94 | 416.0 | -4.82 |
| days payables outstanding | 23.8 | 387.87 | -93.86 |
| days of inventory on hand | 0 | 0 | NaN |
| receivables turnover | 0.23 | 0.22 | 5.07 |
| payables turnover | 3.78 | 0.23 | 1529.74 |
| inventory turnover | 0 | 0 | NaN |
| roe | 0.03 | 0.01 | 131.38 |
| capex per share | 0.02 | 0.14 | -84.39 |
ROE: Return on Equity (ROE) increased to 0.03 on 2024-09-30 Q3 from 0.01 on 2024-06-30 Q2, representing a change of 131.38%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 5.39 on 2024-09-30 Q3 from 12.36 on 2024-06-30 Q2, representing a change of -56.39%. Indicating a decrease in the relative valuation of the company's stock.
Current Ratio: Current Ratio decreased to 5.21 on 2024-09-30 Q3 from 5.67 on 2024-06-30 Q2, representing a change of -7.98%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.93 on 2024-09-30 Q3 from 1.66 on 2024-06-30 Q2, representing a change of -43.82%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
Negative Sentiment: Discounted Cash Flow value is 21.99 which is lower than current price 68.93, indicates the company may be overvalued.
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Positive
Publish Date: 2025-01-14 09:00:00
ENGLEWOOD, Colo. , Jan. 14, 2025 /PRNewswire/ -- XTI Aerospace, Inc. (Nasdaq: XTIA) ("XTI Aerospace" or the "Company"), a pioneer in VTOL and Powered-Lift aircraft solutions, today announced that David Oppenheimer has joined the XTI Corporate Advisory Board.
Sentiment: Positive
Publish Date: 2025-01-07 15:15:43
Olive Garden, KFC, and Shake Shack look like particularly appetizing investments in 2025, according to Oppenheimer analysts.
Sentiment: Neutral
Publish Date: 2025-01-06 13:05:54
It's a new year, and with that, the 2025 S&P 500 forecasts from the big names on Wall Street are in.
Sentiment: Positive
Publish Date: 2024-12-20 16:49:16
Oppenheimer analyst Ken Wong assumed coverage of Roper Technologies with an Outperform rating and $630 price target. The firm sees potential for revenue acceleration with management targeting companies earlier in the S-curve, as opposed to the prior strategy of pursuing established market leaders. The analyst has high confidence that management's decentralized philosophy and competency identifying, nurturing, and operating market leaders will minimize the risks associated with earlier-stage companies while potentially enabling superior long-term value.
Sentiment: Neutral
Publish Date: 2024-12-19 17:15:27
Brian Nagel, Oppenheimer senior analyst, joins 'Closing Bell: Overtime' to discuss Nike earnings and his outlook for the stock.
Sentiment: Positive
Publish Date: 2024-12-17 06:00:00
Strategic Recruitments of Persio 'Tony' Perez, Michael Chatman and Bill Dolan as Managing Directors Builds on Growth Momentum of Fixed Income Team Senior-Level Hires Enhance Oppenheimer's Capabilities in Emerging Markets Sales, Trading and Research Solutions NEW YORK , Dec. 17, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY) — announced today the continued expansion of its Fixed Income Division with the addition of three new Managing Directors to the Emerging Markets Desk in New York. Joining the firm are Persio "Tony" Perez, EM Sales Manager; Michael Chatman, EM Sales; and Bill Dolan, EM Sovereign Trading.
Sentiment: Neutral
Publish Date: 2024-12-09 16:01:00
LIVERMORE, Calif.--(BUSINESS WIRE)--McGrath RentCorp (“McGrath” or the “Company”) (Nasdaq: MGRC), a leading business-to-business rental company in North America, today announced that Joe Hanna, Chief Executive Officer, and Keith Pratt, EVP, and Chief Financial Officer, will participate in investor meetings at the Oppenheimer Midwest Virtual Summit on Wednesday, December 11, 2024. ABOUT MCGRATH: McGrath RentCorp (Nasdaq: MGRC) is a leading business-to-business rental company in North America wit.
Sentiment: Positive
Publish Date: 2024-12-05 17:24:01
Brian Nagel, Oppenheimer senior equity research analyst, joins 'Closing Bell Overtime' to talk Lululemon quarterly results.
Sentiment: Positive
Publish Date: 2024-12-04 09:00:00
Wealth Management Veteran Brings Over 25 Years of Industry Experience Appointment Builds on Firm's Momentum Created by Recent Appointments to Strengthen its Presence in Virginia, Georgia, Tennessee and Texas NEW YORK , Dec. 4, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer), a leading investment bank and wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY), today announced the appointment of Craig Schneider as Regional Director of its Michigan Region. Schneider will lead day-to-day operations for the firm's wealth management business in the state and report to Ed Harrington, Executive Vice President of Oppenheimer's Private Client Division.
Sentiment: Positive
Publish Date: 2024-12-04 08:00:00
PHOENIX, Dec. 04, 2024 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary flexible space solutions, today announced that it will participate in the Oppenheimer Midwest Virtual Summit on December 11, 2024.
Sentiment: Positive
Publish Date: 2024-12-03 07:00:00
—Movers in Rare Disease Summit Will Include Elevator Pitches from Rare Disease Companies with “Key, Near-Term, Potentially Stock-Moving Catalysts”— TEL AVIV, Israel, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that it will participate in Oppenheimer's Movers in Rare Disease Summit on Thursday, December 12, 2024, at the Westin Grand Central in New York City.
Sentiment: Positive
Publish Date: 2024-12-03 07:00:00
TORONTO--(BUSINESS WIRE)--Satellos Bioscience Inc. (TSX:MSCL, OTCQB:MSCLF) (“Satellos”), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, announced today that Frank Gleeson, Co-founder and CEO will participate in Oppenheimer's Movers in Rare Disease Summit taking place in New York City on December 12, 2024. Oppenheimer's Movers in Rare Disease Summit Title: Polypharmacy in DMD and Neuromuscular Disease Forma.
Sentiment: Positive
Publish Date: 2024-11-14 09:03:00
Top 10 U.S. broker-dealer will leverage Pontera's secure platform to manage workplace retirement accounts and help clients optimize their returns NEW YORK , Nov. 14, 2024 /PRNewswire/ -- Pontera™, the fintech company helping retirement savers receive professional 401(k) account management from their trusted financial advisor, today announced a partnership with Oppenheimer & Co., Inc., a premier U.S. wealth management and investment banking firm. Pontera, a fintech on a mission to help Americans retire better, has partnered with Oppenheimer, a top 10 US brokerage.
Sentiment: Positive
Publish Date: 2024-11-13 12:30:00
Event Gathered CPAs and Other Trusted Industry Professionals with Select Group of Oppenheimer Advisors, Investment Managers and Senior Leadership to Collaborate on Strategies to Deliver Enhanced Client Service PAG Referral and Partnership Program Model Enables Accounting Firms and Others to Access Oppenheimer's Wealth Management, Capital Markets, and Investment Banking Capabilities NEW YORK , Nov. 13, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer) — a leading wealth management and investment banking firm, and subsidiary of Oppenheimer Holdings (NYSE: OPY) — today announced the completion of its 20th annual Professionals Alliance Group (PAG) Conference. The event, held November 12-13 at the firm's New York headquarters, brought together a select group of Oppenheimer's financial advisors, investment managers and senior leadership with Certified Public Accounting firms and other trusted industry partners to discuss macro trends and strategies to best serve clients.
Sentiment: Neutral
Publish Date: 2024-11-12 08:57:28
Brian Nagel, Oppenheimer senior analyst, joins 'Squawk Box' to break down Home Depot's Q3 earnings results.
Sentiment: Positive
Publish Date: 2024-11-08 14:27:27
Oppenheimer analyst Matthew Biegler lowered the firm's price target on Vor Bio to $8 from $10 and keeps an Outperform rating on the shares following the Q3 report. The firm cites updated spending estimates based on guidance from management for the target. It acknowledges Vor's "financial overhang," but still views the company as a "deeply discounted innovator in the biotech sector."
Sentiment: Neutral
Publish Date: 2024-11-05 14:12:54
The Investment Committee debate the big bank names.
Sentiment: Positive
Publish Date: 2024-10-26 09:10:42
Oppenheimer's earnings report show strength in mid-market capital markets franchise as well as solid growth in the rest of its AUM and commission based businesses. Risk taking in public markets has driven the bulk of the company's performance, and capital markets did well despite the lack of major PE activity. OPY looks attractive in terms of valuation, with forward multiples below 10x, making it cheaper compared to peers like Lazard, which trades at around 20x.
Sentiment: Positive
Publish Date: 2024-10-25 08:00:00
NEW YORK , Oct. 25, 2024 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $24.5 million or $2.38 basic earnings per share for the third quarter of 2024, compared with net income of $13.9 million or $1.32 basic earnings per share for the third quarter of 2023. Revenue for the third quarter of 2024 was $373.4 million, an increase of 19.4%, compared to revenue of $312.7 million for the third quarter of 2023.
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
